Model based design of inhibitors for c-jun
Pallavi Chauhan1, Madhvi Shakya
1Department of Bioinformatics,MANIT, Bhopal, MP, India. pallavi.chauhan2006@gmail.com
Bioinformation
|October 27, 2010
Summary
Stress and UV damage activate molecular pathways that degrade skin collagen, causing wrinkles. Inhibiting c-jun, a key protein in these cascades, offers a promising strategy to reduce skin aging and collagen loss.
Area of Science:
- Biochemistry
- Dermatology
- Computational Biology
Background:
- Skin aging, including wrinkle formation, is driven by molecular cascades initiated by environmental stressors like UV radiation and pollutants.
- These cascades involve specific receptors (EGFR, PDGFR, PAFR, IL1R, TNFRB) and lead to collagen degradation via matrix metalloproteinases.
- The transcription factor c-jun plays a crucial role in these signaling pathways, making it a potential target for intervention.
Purpose of the Study:
- To computationally model the 3D structure of c-jun.
- To design and evaluate novel ligands capable of inhibiting c-jun's activity.
- To explore potential therapeutic strategies for mitigating stress-induced skin aging.
Main Methods:
- Segment-based homology modeling using MODELLER 9v5 to construct the c-jun 3D structure.
- Model validation through PROCHECK, WHAT CHECK, and RMSD/RMSF analysis.
- Ligand design using LIGANDSCOUT, interaction studies with AUTODOCK, and virtual screening of analogues using MOLEGRO Virtual Docker.
Main Results:
- A validated 3D model of c-jun was successfully generated.
- Novel ligands were designed and computationally evaluated for their binding affinity to c-jun.
- Constructed analogues demonstrated favorable binding interactions with the target receptor sites, suggesting inhibitory potential.
Conclusions:
- Inhibiting c-jun represents a viable strategy to counteract collagen degradation and reduce wrinkle formation.
- Computational methods provide a powerful platform for designing targeted inhibitors against key proteins involved in skin aging.
- Further experimental validation is necessary to confirm the efficacy of the designed ligands in biological assays.
Related Concept Videos
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:34Inhibition of CDK Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
01:52Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
01:28Structure-Activity Relationships and Drug Design
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
02:00Molecular Models
Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.